<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: This study performed to determine the effects of <z:chebi fb="3" ids="37445">folate</z:chebi> supplementation on indices of glycemic control, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and <z:chebi fb="23" ids="18059">lipid</z:chebi> profile in overweight and <z:mp ids='MP_0001261'>obese</z:mp> men with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> under <z:chebi fb="0" ids="6801">metformin</z:chebi> (at least 1500 mg daily) treatment </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The study was a double-blind randomized controlled clinical trial </plain></SENT>
<SENT sid="2" pm="."><plain>Forty-eight overweight and <z:mp ids='MP_0001261'>obese</z:mp> men (aged 58.2±8.9 years; BMI=28.6±2.9 kg/m(2)) with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> participated in the study </plain></SENT>
<SENT sid="3" pm="."><plain>Patients were divided randomly into two groups of <z:chebi fb="9" ids="27470">folic acid</z:chebi> (5 mg/d) and placebo </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients received the tablets for eight weeks </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Supplementation with <z:chebi fb="9" ids="27470">folic acid</z:chebi> led to 8% decrease in HbA1C (p=0.048), 7.5% in fasting blood <z:chebi fb="105" ids="17234">glucose</z:chebi> (p=0.051), 16.2% in serum insulin (p=0.021), 20.5% in <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> (p=0.041) and 21.2% in plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi> (p=0.000) </plain></SENT>
<SENT sid="6" pm="."><plain>A significant increase in serum <z:chebi fb="3" ids="37445">folate</z:chebi> and <z:chebi fb="13" ids="33611">B12</z:chebi> levels (19% and 17.3%, p=0.000, respectively) were observed in the <z:chebi fb="9" ids="27470">folic acid</z:chebi> group, whereas no significant changes occurred in the placebo group </plain></SENT>
<SENT sid="7" pm="."><plain>Also, in the <z:chebi fb="9" ids="27470">folic acid</z:chebi> and placebo groups, there were no significant changes in body weight </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: <z:chebi fb="9" ids="27470">Folic acid</z:chebi> supplementation lowered plasma level of <z:chebi fb="0" ids="17230">homocysteine</z:chebi>, improved glycemic control and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>